Tetratherix Limited 20262026 Notice of Annual General MeetingAnchored by ScienceASX Release12 October 2026ASX:TTXTetratherix Limited (TTX) attaches the following documents relating to its 2026 Annual General Meeting to be held at the TTXCampus at 9:00am (AEDT) on 12 November 2026:Notice of Annual...
Tetratherix: Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 18 pages · English
Summary by 6ix AI
Tetratherix Limited has issued a notice for its upcoming Annual General Meeting scheduled for November, detailing important voting information and resolutions to be considered. The notice includes the agenda, which covers the adoption of the Remuneration Report, election of directors, and the appointment of an auditor. Shareholders are encouraged to submit questions in advance and are reminded of the importance of their votes during the meeting. The filing serves to inform shareholders about the meeting logistics and the resolutions that will be voted on.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Tetratherix
- Application for quotation of securities - TTX
- Tegenix FDA Review Progress
- Notification regarding unquoted securities - TTX
- Line of sight ophthalmic tissue spacing US revenue
- Tetratherix Ships First US Polymer, Revenue Begins
Later from Tetratherix
- Notification of cessation of securities - TTX
- TegenEOS Biologic Pathway
- Quarterly Activities/Appendix 4C Cash Flow Report
- Details of Auditor Appointment/Resignation
Follow Tetratherix into a list and get an email when it puts out news.
Follow Tetratherix